Cargando…
Neuronal hypoxia in vitro: Investigation of therapeutic principles of HUCB-MNC and CD133(+ )stem cells
BACKGROUND: The therapeutic capacity of human umbilical cord blood mononuclear cells (HUCB-MNC) and stem cells derived thereof is documented in animal models of focal cerebral ischemia, while mechanisms behind the reduction of lesion size and the observed improvement of behavioral skills still remai...
Autores principales: | Reich, Doreen M, Hau, Susann, Stahl, Tobias, Scholz, Markus, Naumann, Wilfried, Emmrich, Frank, Boltze, Johannes, Kamprad, Manja |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2569042/ https://www.ncbi.nlm.nih.gov/pubmed/18803816 http://dx.doi.org/10.1186/1471-2202-9-91 |
Ejemplares similares
-
Evidence for neuroprotective properties of human umbilical cord blood cells after neuronal hypoxia in vitro
por: Hau, Susann, et al.
Publicado: (2008) -
Experimental treatment of stroke in spontaneously hypertensive rats by CD34(+ )and CD34(-) cord blood cells
por: Boltze, Johannes, et al.
Publicado: (2005) -
Effectiveness of cytopenia prophylaxis for different filgrastim and pegfilgrastim schedules in a chemotherapy mouse model
por: Scholz, Markus, et al.
Publicado: (2009) -
Smoking behavior detection algorithm based on YOLOv8-MNC
por: Wang, Zhong, et al.
Publicado: (2023) -
Phase 1 clinical study of cell therapy with effective-mononuclear cells (E-MNC) for radiogenic xerostomia (first-in-human study) (FIH study on E-MNC therapy for radiogenic xerostomia)
por: Sumita, Yoshinori, et al.
Publicado: (2020)